研究将Ozempic和类似药物与可能增加抑郁风险的潜在大脑变化联系起来。 Study links Ozempic and similar drugs to potential brain changes that may increase depression risk.

最近的一项研究表明,像Ozempic这种有助于管理血糖和食欲的药物可能会导致大脑发生变化,导致抑郁症。 A recent study indicates that medications like Ozempic, which help manage blood sugar and appetite, might cause changes in the brain that could lead to depression. 这些药物,称为GLP-1受体激动剂, 模仿大脑、内脏和胰腺中发现的自然荷尔蒙。 These drugs, known as GLP-1 receptor agonists, mimic a natural hormone found in the brain, gut, and pancreas. 研究表明,这些药物与低多巴胺水平者患抑郁症和自杀的风险增加之间存在联系,不过还需要进行更多的调查。 The research suggests a link between these medications and an increased risk of depression and suicide in people with low dopamine levels, though more investigation is needed.